Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.

PDRN is effective and safe for healing wounds and skin issues.

Erlotinib can cause nonscarring hair loss and itchy skin.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

The synthetic retinoid EC23 thickens skin and promotes hair growth more effectively and with a lower dose than natural retinoids.

Anti-EGFR therapy can cause skin issues, but FGF7 treatment might help.

Androgen receptors help prostate cancer cells grow and resist drugs.

Blocking IL-8 can reduce skin rashes from cancer treatment.

DORN1 receptor affects eATP-induced stomatal changes but not eADP in Arabidopsis thaliana.

CRISPR gene editing reduces harmful molecules in cells from Emery–Dreifuss Muscular Dystrophy patients.

Targeted cancer therapies can cause skin side effects, but activating SOS in the skin may help reduce them.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

JW0061 may be a new treatment for hair loss by promoting hair growth through WNT signaling.

LGD1069 effectively prevents breast tumors in mice without toxicity.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Iressa often causes skin issues like acne and dryness in lung cancer patients.

WYE-130600 may cause skin thickening and irritation.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

EDA signaling is linked to skin disorders, various cancers, and liver disease.

Epidermal growth factor helps skin and hair regeneration but needs more research for better understanding.

Understanding EGFR roles could lead to new hair loss treatments.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Future research on ectodysplasin should explore its role in diseases, stem cells, and evolution, and continue developing treatments for genetic disorders like hypohidrotic ectodermal dysplasia.

New compounds may help treat prostate issues without affecting androgen receptors.

A new topical treatment for hair loss is effective and safe with faster results.

A new topical treatment for hair loss is effective and safe with faster results.

A new topical treatment for hair loss is effective and safe with faster results.

A new topical treatment for hair loss is effective and safe with faster results.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.